|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
i Family
Departments of Biochemistry (A.C.E., P.J.C.), Pharmacology & Cancer Biology (P.J.C.), Duke University Medical Center, Durham, North Carolina; Department of Pharmacology, University of Washington, Seattle, Washington (J.L.G.); and Department of Cell Biology and Physiology, Washington University, St. Louis, Missouri (M.E.L.)
As part of a program to elucidate signaling processes controlled by the heterotrimeric G protein G
z, a human fetal brain cDNA library was screened for proteins that specifically interact with the activated form of G
z. One of the most-encountered molecules in this screen was Eya2, a member of the Eyes absent family of proteins. Mammalian Eya proteins are predominantly cytosolic proteins that are known to interact with members of the Sine oculis (Six) family of homeodomain transcription factors. This interaction facilitates the translocation of Eya into the nucleus, where the Eya/Six complex regulates transcription during critical stages of embryonic development. In vitro binding studies confirmed that G
z interacts with Eya2 in an activation-dependent fashion; furthermore, most other members of the G
i family including G
i1, G
i2, and G
i3 were found to interact with Eya2. It is interesting that one of the most abundant G
i proteins, G
o, did not interact with Eya2. Coexpression of the activated forms of G
i1, G
i2, and G
i3, but not G
o, with Eya2 recruited Eya2 to the plasma membrane, prevented Eya2 translocation into the nucleus, and abrogated Eya2/Six4-mediated transcription. In addition, Eya2 impinged on G protein-mediated signaling, as evidenced by its ability to relieve G
i2-mediated inhibition of adenylyl cyclase. These results demonstrate that the interaction between the G
i proteins and Eya2 may impact on seemingly disparate regulatory events involving both classes of proteins.
Received for publication June 21, 2004.
Accepted for publication August 12, 2004.
Address correspondence to: Dr. Patrick J. Casey, Department of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3813, Durham, NC 27710-3813. E-mail: casey006{at}mc.duke.edu
This article has been cited by other articles:
![]() |
M. E. Kimple, A. B. Nixon, P. Kelly, C. L. Bailey, K. H. Young, T. A. Fields, and P. J. Casey A Role for Gz in Pancreatic Islet {beta}-Cell Biology J. Biol. Chem., September 9, 2005; 280(36): 31708 - 31713. [Abstract] [Full Text] [PDF] |
||||